Key Takeaways
- • New to The Street Show #777 premieres at 6:30 p.m. ET on Bloomberg Television as sponsored programming, distributed across the U.S., Latin America, MENA and Southeast Asia, according to an ACCESS Newswire press release dated October 24, 2026.
- • The show features executive interviews with Bilal Adam (Stewards Investment Capital), Cuong Do (BioVie Inc., NASDAQ:BIVI), Bill Mobley (FreeCast, NASDAQ:CAST) and Brent Nelson (American Fusion Inc., OTCQB:AMFN), hosted by Jane King from the NYSE floor.
- • BioVie reports that its investigational oral therapy bezisterim showed statistically significant improvements in fatigue, malaise and cognitive impairment in a high-symptom-burden long COVID trial subgroup, with findings requiring confirmation in a Phase 3 trial.
- • FreeCast positions its software as infrastructure enabling telecom and internet providers to launch branded entertainment hubs, and clarifies that its PEAC metric measures potential reach, not active users or revenue.
- • The segment is paid sponsored programming; New to The Street receives compensation from featured companies in cash and/or securities.
Summary
New to The Street's Show #777 premieres tonight at 6:30 p.m. ET on Bloomberg Television as sponsored programming. The episode, hosted by Jane King and opening from the floor of the New York Stock Exchange, features four companies the platform describes as working at the frontiers of capital allocation, healthcare, media technology and energy. The broadcast is distributed across the United States, Latin America, the Middle East and North Africa, and Southeast Asia.
Bilal Adam, CEO of Stewards Investment Capital, discusses the firm's international strategy, which spans South Africa, Mauritius, the United States and Monaco. According to the release, the firm offers private credit and diversified investment opportunities to institutional investors, pension funds, family offices and high-net-worth individuals, and is involved in telecommunications infrastructure investments in underserved African communities. Adam also discusses the relationship with Nasdaq-listed Stewards Inc. (NASDAQ:SWRD), led by CEO and President Shaun Quin.
BioVie Inc. CEO Cuong Do reports that results from the ADDRESS-LC trial in long COVID and the SUNRISE-PD trial in Parkinson's disease were presented at the American Neurological Association annual meeting and published in Annals of Neurology. Do says patients with high symptom burden treated with bezisterim showed clinically relevant and statistically significant improvements in fatigue, malaise and cognitive impairment. The company states that all 12 advisors who reviewed the results urged a move to a confirmatory Phase 3 trial, that it has been invited to present at the NIH's next RECOVER annual meeting, and that it is seeking an FDA meeting on Phase 3 design. The release notes these findings require confirmation in a Phase 3 trial.
FreeCast founder and CEO William Mobley describes the company as providing software infrastructure that lets telecom companies, wireless carriers, internet providers, satellite companies and membership organizations launch branded entertainment hubs. Mobley introduces PEAC, or partner-enabled addressable customers, which measures potential distribution reach through enterprise agreements. He states clearly that PEAC does not represent active users, paying subscribers or confirmed revenue.
American Fusion Inc. Executive Chairman Brent Nelson presents the Texatron Fusion Engine, an aneutronic fusion platform the company describes for modular deployment across industrial, commercial, defense and grid-constrained applications. Nelson describes 12 engine models using a deuterium and helium-3 fuel cycle, which he says produces no radioactive waste. Nelson said, "We think that we're the first ones to crack that commercial nut." These technology claims are the company's own and have not been independently verified in the release.
The release notes that New to The Street receives compensation from featured companies and that the program is sponsored content. It also states that the release contains forward-looking statements subject to risk, and that it is not an offer to buy or sell any security.
Bilal Adam, CEO of Stewards Investment Capital, discusses the firm's international strategy, which spans South Africa, Mauritius, the United States and Monaco. According to the release, the firm offers private credit and diversified investment opportunities to institutional investors, pension funds, family offices and high-net-worth individuals, and is involved in telecommunications infrastructure investments in underserved African communities. Adam also discusses the relationship with Nasdaq-listed Stewards Inc. (NASDAQ:SWRD), led by CEO and President Shaun Quin.
BioVie Inc. CEO Cuong Do reports that results from the ADDRESS-LC trial in long COVID and the SUNRISE-PD trial in Parkinson's disease were presented at the American Neurological Association annual meeting and published in Annals of Neurology. Do says patients with high symptom burden treated with bezisterim showed clinically relevant and statistically significant improvements in fatigue, malaise and cognitive impairment. The company states that all 12 advisors who reviewed the results urged a move to a confirmatory Phase 3 trial, that it has been invited to present at the NIH's next RECOVER annual meeting, and that it is seeking an FDA meeting on Phase 3 design. The release notes these findings require confirmation in a Phase 3 trial.
FreeCast founder and CEO William Mobley describes the company as providing software infrastructure that lets telecom companies, wireless carriers, internet providers, satellite companies and membership organizations launch branded entertainment hubs. Mobley introduces PEAC, or partner-enabled addressable customers, which measures potential distribution reach through enterprise agreements. He states clearly that PEAC does not represent active users, paying subscribers or confirmed revenue.
American Fusion Inc. Executive Chairman Brent Nelson presents the Texatron Fusion Engine, an aneutronic fusion platform the company describes for modular deployment across industrial, commercial, defense and grid-constrained applications. Nelson describes 12 engine models using a deuterium and helium-3 fuel cycle, which he says produces no radioactive waste. Nelson said, "We think that we're the first ones to crack that commercial nut." These technology claims are the company's own and have not been independently verified in the release.
The release notes that New to The Street receives compensation from featured companies and that the program is sponsored content. It also states that the release contains forward-looking statements subject to risk, and that it is not an offer to buy or sell any security.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.